Informazioni sul prodotto
TL4-12 is a synthetic, immunomodulatory drug that has been shown to inhibit tumor growth in vivo. TL4-12 binds to the receptor for the cytokine IL-2 and downregulates its signalling. It also inhibits ikzf1, a transcription factor that regulates cell cycle progression and cell proliferation, which may contribute to its antitumor effects. The mechanism of action of TL4-12 has not been fully elucidated, but it has been shown to inhibit the growth of cells in culture. This drug is currently being evaluated in clinical trials as a treatment for hepatitis C virus infection and cancer. Constitutive activation of TL4-12 leads to inhibition of constitutive activation of other signalling pathways such as JAK/STAT3 and NFκB.
Proprietà chimiche
Richiesta tecnica su: 3D-VPC82012 TL4-12
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
